Keratoprosthesis

Last updated
Boston Kpro type 1 titanium posterior plate Boston Kpro type 1 Titanium posterior plate.JPG
Boston Kpro type 1 titanium posterior plate

Keratoprosthesis is a surgical procedure where a diseased cornea is replaced with an artificial cornea. Traditionally, keratoprosthesis is recommended after a person has had a failure of one or more donor corneal transplants. [1] More recently, a less invasive, non-penetrating artificial cornea has been developed which can be used in more routine cases of corneal blindness. While conventional cornea transplant uses donor tissue for transplant, an artificial cornea is used in the keratoprosthesis procedure. The surgery is performed to restore vision in patients with severely damaged cornea due to congenital birth defects, infections, injuries and burns.

Contents

Keratoprotheses are made of clear plastic with excellent tissue tolerance and optical properties. They vary in design, size and even the implantation techniques may differ across different treatment centers. The procedure is done by ophthalmologists, often on an outpatient basis.

The idea of artificial cornea was first proposed in 1789 by French ophthalmologist Guillaume Pellier de Quengsy. [2] [3] [4]

Types

Although many keratoprostheses have been developed, only four models are currently in commercial use: the Boston keratoprosthesis, osteo-odonto-keratoprosthesis (OOKP), AlphaCor and the KeraKlear artificial cornea.

Indications

Indications for penetrating keratoprotheses include the following:

Indications for non-penetrating keratoprostheses include the following:

Pre-operative examination

In most cases, the patient meets the ophthalmologist for eye examination and other tests weeks or months preceding surgery. During the meeting, the ophthalmologist will examine the eye and diagnose its condition. The doctor will also record the history of the patient's health and other previous eye treatments, if any. The doctor will discuss the risks and benefits of the surgery. If the patient elects for the surgery, the doctor will have the patient sign an informed consent form. The doctor may also perform physical and lab examinations, such as an X-ray, an EKG, a slit lamp test, an ultrasound B-scan, or an A-scan.

The surgery date and time is also set, and the patient will also be told where the surgery will take place. The patient can also make any other queries regarding the procedure.

Patient selection

Procedure

On the day of the procedure, the patient will arrive to the hospital or laser center where the surgery is to be performed. After a brief physical examination, he/she will be taken to the operating room. General anesthesia or local anesthesia is given before the surgery begins.

An eyelid speculum is used to keep the eye open throughout the surgery. Some lubrication may be used to prevent the eye from drying. Depending on the type of keratoprosthesis used, the surgery may involve a full thickness replacement of the cornea or the placement of an intralamellar implant. For the Alphacor a manual incision is used to create a corneal pocket and a punch is used to create an opening through the posterior cornea into the anterior chamber. The Alphacor is then inserted into the corneal pocket to allow for bio-integration after several months, a second procedure is used to remove part of the anterior cornea to allow light to reach the retina. In the case of the KeraKlear, the intralamellar pocket is created with a femtosecond laser or a corneal pocket making microkeratome. The posterior cornea is left intact.

Typically, there is a follow up session few days after surgery, when patients' complaints are addressed and modifications are made, if needed.

Since keratoprosthesis surgeries are evolving, constant attempts are being made to improve the outcome of the surgery. Also, the material and design used in the artificial cornea may vary and as a result of this, there can be minor variations in surgical procedure as well.

The surgery is done on an outpatient basis with the patient returning home the same day.

Risks

Though the rate of success with keratoprosthesis is high, in rare cases, certain serious complications could occur.

Usage of keratoprosthesis is typically considered when multiple donor corneal transplants have failed for a patient. A Cochrane Review found no controlled trials comparing the effectiveness of artificial corneas with donor corneas for repeat corneas transplantations. [1]

Prognosis

The primary purpose of keratoprosthesis is to improve vision in patients with complex ocular diseases who are at high risk for donor graft failure. After an impressive success record with keratoprosthesis in adults, the procedure is used to treat young patients with severe ocular deformities.

Economics

Keratoprosthesis is continuously evolving with newer generation materials that seek to improve treatment outcomes. However, the cost of surgery is on the expensive side and can typically run up to $35,000 in the US. In order to obtain surgical treatment at a lower cost, many patients choose to get the treatment done from popular medical tourism destinations like India and Singapore where the cost of treatment may be as little as one fourth the cost as in the US or UK.

Related Research Articles

<span class="mw-page-title-main">Keratoconus</span> Medical condition involving the eye

Keratoconus (KC) is a disorder of the eye that results in progressive thinning of the cornea. This may result in blurry vision, double vision, nearsightedness, irregular astigmatism, and light sensitivity leading to poor quality-of-life. Usually both eyes are affected. In more severe cases a scarring or a circle may be seen within the cornea.

<span class="mw-page-title-main">LASIK</span> Corrective ophthalmological surgery

LASIK or Lasik, commonly referred to as laser eye surgery or laser vision correction, is a type of refractive surgery for the correction of myopia, hyperopia, and an actual cure for astigmatism, since it is in the cornea. LASIK surgery is performed by an ophthalmologist who uses a laser or microkeratome to reshape the eye's cornea in order to improve visual acuity. For most people, LASIK provides a long-lasting alternative to eyeglasses or contact lenses.

<span class="mw-page-title-main">Eye surgery</span> Surgery performed on the eye or its adnexa

Eye surgery, also known as ophthalmic or ocular surgery, is surgery performed on the eye or its adnexa, by an ophthalmologist. Eye surgery is part of ophthalmology. The eye is a fragile organ, and requires due care before, during, and after a surgical procedure to minimize or prevent further damage. An eye surgeon is responsible for selecting the appropriate surgical procedure for the patient, and for taking the necessary safety precautions. Mentions of eye surgery can be found in several ancient texts dating back as early as 1800 BC, with cataract treatment starting in the fifth century BC. It continues to be a widely practiced class of surgery, with various techniques having been developed for treating eye problems.

<span class="mw-page-title-main">Refractive surgery</span> Surgery to treat common vision disorders

Refractive eye surgery is optional eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. This can include various methods of surgical remodeling of the cornea (keratomileusis), lens implantation or lens replacement. The most common methods today use excimer lasers to reshape the curvature of the cornea. Refractive eye surgeries are used to treat common vision disorders such as myopia, hyperopia, presbyopia and astigmatism.

<span class="mw-page-title-main">Corneal transplantation</span> Surgical procedure of repairing corneal tissue to treat corneal blindness

Corneal transplantation, also known as corneal grafting, is a surgical procedure where a damaged or diseased cornea is replaced by donated corneal tissue. When the entire cornea is replaced it is known as penetrating keratoplasty and when only part of the cornea is replaced it is known as lamellar keratoplasty. Keratoplasty simply means surgery to the cornea. The graft is taken from a recently deceased individual with no known diseases or other factors that may affect the chance of survival of the donated tissue or the health of the recipient.

The Lions Eye Institute (LEI) is an Australian medical research institute affiliated with the University of Western Australia. It was established in 1983 with support of the Lions Clubs of Western Australia and headquartered in the Perth suburb of Nedlands, Western Australia. The LEI is a not-for-profit centre of excellence that combines an ophthalmic clinic with scientific discovery developing techniques for the prevention of blindness and the reduction of pain from blinding eye conditions.

Eye banks recover, prepare and deliver donated eyes for cornea transplants and research. The first successful cornea transplant was performed in 1905 and the first eye bank was founded in 1944. Currently, in the United States, eye banks provide tissue for over 80,000 cornea transplants each year to treat conditions such as keratoconus and corneal scarring. In some cases, the white of the eye (sclera) is used to surgically repair recipient eyes. Unlike other organs and tissues, there is an adequate supply of corneas for transplants in the United States, and excess tissue is exported internationally, where there are shortages in many countries, due to greater demand and a less-developed eye banking infrastructure.

<span class="mw-page-title-main">Scleral lens</span> Large contact lens resting on the sclera, creating a tear-filled vault over the cornea

A scleral lens, also known as a scleral contact lens, is a large contact lens that rests on the sclera and creates a tear-filled vault over the cornea. Scleral lenses are designed to treat a variety of eye conditions, many of which do not respond to other forms of treatment.

Keratoglobus is a degenerative non-inflammatory disorder of the eye in which structural changes within the cornea cause it to become extremely thin and change to a more globular shape than its normal gradual curve. It causes corneal thinning, primarily at the margins, resulting in a spherical, slightly enlarged eye.

<span class="mw-page-title-main">Pellucid marginal degeneration</span> Degenerative corneal condition

Pellucid marginal degeneration (PMD) is a degenerative corneal condition, often confused with keratoconus. It typically presents with painless vision loss affecting both eyes. Rarely, it may cause acute vision loss with severe pain due to perforation of the cornea. It is typically characterized by a clear, bilateral thinning (ectasia) in the inferior and peripheral region of the cornea, although some cases affect only one eye. The cause of the disease remains unclear.

Osteo-odonto-keratoprosthesis (OOKP) is a medical procedure to restore vision in the most severe cases of corneal and ocular surface patients. It includes removal of a tooth from the patient or a donor.

<span class="mw-page-title-main">Boston keratoprosthesis</span> Prosthetic cornea

Boston keratoprosthesis is a collar button design keratoprosthesis or artificial cornea. It is composed of a front plate with a stem, which houses the optical portion of the device, a back plate and a titanium locking c-ring. It is available in type I and type II formats. The type I design is used much more frequently than the type II which is reserved for severe end stage dry eye conditions and is similar to the type I except it has a 2 mm anterior nub designed to penetrate through a tarsorrhaphy. The type I format will be discussed here as it is more commonly used.

<span class="mw-page-title-main">Gholam A. Peyman</span> Iranian-American ophthalmologist and retina surgeon known for inventing LASIK eye surgery

Gholam A. Peyman is an ophthalmologist, retina surgeon, and inventor. He is best known for his invention of LASIK eye surgery, a vision correction procedure designed to allow people to see clearly without glasses. He was awarded the first US patent for the procedure in 1989.

Bascom Palmer Eye Institute is the University of Miami School of Medicine's ophthalmic care, research, and education center. The institute is based in the Health District of Miami, Florida, and has been ranked consistently as the best eye hospital and vision research center in the nation.

Peter S. Hersh is an American ophthalmologist and specialist in LASIK eye surgery, keratoconus, and diseases of the cornea. He co-authored the article in the journal Ophthalmology that presented the results of the study that led to the first approval by the U.S. Food and Drug Administration (FDA) of the excimer laser for the correction of nearsightedness in the United States. Hersh was also medical monitor of the study that led to approval of corneal collagen crosslinking for the treatment of keratoconus.

The Universitäts-Augenklinik Düsseldorf is the department of Ophthalmology of the University Hospital of Düsseldorf in Germany. It is an internationally renown centre for corneal transplantation, ocular surface disease and management of associated disorders ranging from Glaucoma to oculoplastic surgery. Further subspecialist expertise is established for the diagnosis and surgical and medical treatment of vitreoretinal and macular disorders as well as strabismus.

<span class="mw-page-title-main">Limbal stem cell</span>

Limbal stem cells, also known as corneal epithelial stem cells, are unipotent stem cells located in the basal epithelial layer of the corneal limbus. They form the border between the cornea and the sclera. Characteristics of limbal stem cells include a slow turnover rate, high proliferative potential, clonogenicity, expression of stem cell markers, as well as the ability to regenerate the entire corneal epithelium. Limbal stem cell proliferation has the role of maintaining the cornea; for example, by replacing cells that are lost via tears. Additionally, these cells also prevent the conjunctival epithelial cells from migrating onto the surface of the cornea.

<span class="mw-page-title-main">Corneal button</span> Replacement cormea for transplantation

A corneal button is a replacement cornea to be transplanted in the place of a damaged or diseased cornea normally approximately 8.5–9.0mm in diameter. It is used in a corneal transplantation procedure whereby the whole, or part, of a cornea is replaced. The donor tissue can now be held for days to even weeks of the donor's death and is normally a small, rounded shape. The main use of the corneal button is during procedures where the entirety of the cornea needs to be replaced, also known as penetrating keratoplasty.

<span class="mw-page-title-main">Corneal opacity</span> Medical condition

The human cornea is a transparent membrane which allows light to pass through it. The word corneal opacification literally means loss of normal transparency of cornea. The term corneal opacity is used particularly for the loss of transparency of cornea due to scarring. Transparency of the cornea is dependent on the uniform diameter and the regular spacing and arrangement of the collagen fibrils within the stroma. Alterations in the spacing of collagen fibrils in a variety of conditions including corneal edema, scars, and macular corneal dystrophy is clinically manifested as corneal opacity. The term corneal blindness is commonly used to describe blindness due to corneal opacity.

<span class="mw-page-title-main">Peter Szurman</span> German ophthalmologist

Peter Szurman is a German ophthalmologist, scientist, and professor of ophthalmology in Sulzbach/Saar.

References

  1. 1 2 Chen, Masako; Ng, Sueko M.; Akpek, Esen K.; Ahmad, Sumayya (13 May 2020). "Artificial corneas versus donor corneas for repeat corneal transplants". The Cochrane Database of Systematic Reviews. 2020 (5): CD009561. doi:10.1002/14651858.CD009561.pub3. ISSN   1469-493X. PMC   7388900 . PMID   32408386.
  2. de Quengsy, Guillaume Pellier (1789). Précis au cours d'operations sur la chirurgie des yeux [Accuracy during eye surgery operations] (in French). Paris: Didot. OCLC   14829290.[ page needed ]
  3. Alio, Jorge L; Abdelghany, Ahmed A; Abu-Mustafa, Sabat K; Zein, G (2015). "A new epidescemetic keratoprosthesis: Pilot investigation and proof of concept of a new alternative solution for corneal blindness". British Journal of Ophthalmology. 99 (11): 1483–7. doi:10.1136/bjophthalmol-2014-306264. PMID   25868791. S2CID   12099320.
  4. Alio, Jorge L; Abbouda, Alessandro; Vega-Estrada, Alfredo (2018). "An Innovative Intrastromal Keratoprosthesis Surgery Assisted by Femtosecond Laser". European Journal of Ophthalmology. 24 (4): 490–3. doi:10.5301/ejo.5000435. PMID   24519504. S2CID   20451052.